Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone

Psychopharmacology (Berl)
July 2010
https://pubmed.ncbi.nlm.nih.gov/20386884/

Rationale: Prescription opioid abuse has risen dramatically in the United States as clinicians have increased opioid prescribing for alleviation of both acute and chronic pain. Opioid analgesics with decreased risk for abuse are needed.

Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

Support Care Cancer
10 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/35001215/

Naltrexone at low doses (LDN) and its relevance to cancer therapy

Expert Rev Anticancer Ther
02 Feb 2022
https://pubmed.ncbi.nlm.nih.gov/35107043/

Claudia Christian - The Sinclair Method (2014 Conference) (LDN, low dose naltrexone)